Abstract
To determine key themes and issues identified by Evidence Review Groups (ERG) and the NICE committee during the NICE Highly Specialised Technology (HST) Appraisal process. Also, to explore the relationship between issues that limit the ability of the NICE committee to approve a product, as well as looking at ways that companies mitigate uncertainty in their appraisals.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
